miR-29c |
Down |
Glioma |
Suppression |
Suppression |
VEGF, MMP2 |
57 |
miR-195 |
Down |
Hepatocellular carcinoma |
Suppression |
Suppression |
VEGF, VAV2, CDC42 |
58 |
miR-199a-3p |
Down |
Hepatocellular carcinoma |
Suppression |
Suppression |
VEGFA, VEGFR1, VEGFR2, HGF, MMP2 |
59 |
miR-497 |
Down |
Hepatocellular carcinoma, breast cancer, pancreatic cancer |
Suppression |
Suppression |
VEGFA, AEG-1, VEGFR2 |
60, 61, 62 |
miR-519c |
Down |
Lung adenocarcinoma, breast cancer |
Suppression |
Suppression |
HIF-1alpha |
63 |
miR-145 |
Down |
Gastric cancer, neuroblastoma |
Suppression |
Suppression |
HIF-2alpha, Ets1 |
64, 65 |
miR-107 |
Down |
Colon cancer |
Suppression |
Suppression |
HIF-1beta, VEGF, BDNF |
67 |
miR-542-3p |
Down |
Breast cancer, hepatocellular carcinoma |
Suppression |
Suppression |
ANG2 |
71, 72 |
miR-543 |
Down |
Osteosarcoma, colorectal cancer |
Suppression |
Suppression |
ANG2, KRAS, MTA1, HMGA2 |
73, 74 |
miR-9 |
Down |
Neuroblastoma |
Suppression |
Suppression |
MMP14 |
75 |
miR-181-5p |
Down |
Breast cancer, colon cancer |
Suppression |
Suppression |
MMP14 |
76 |
miR-454 |
Down |
Pancreatic cancer |
Suppression |
Suppression |
LRP6 |
79 |
miR-126-3p |
Down |
Oral squamous cell carcinoma, hepatocellular carcinoma |
Suppression |
Suppression |
VEGFA, LRP6, PIK3R2 |
80, 81 |
miR-26a |
Down |
Hepatocellular carcinoma |
Suppression |
Suppression |
IL-6, HGF |
83, 84 |
miR-451 |
Down |
Osteosarcoma, hepatocellular carcinoma |
Suppression |
Suppression |
IL-6R |
85, 86 |
miR-34a |
Down |
Bladder cancer |
Suppression |
Suppression |
CD44 |
88 |
miR-101 |
Down |
Glioblastoma, nasopharygeal carcinoma |
Suppression |
Suppression |
EZH2, ITGA3 |
89, 90 |
miR-124 |
Down |
Bladder cancer, cervical cancer |
Suppression |
Suppression |
UHRF1, AmotL1 |
91, 92 |
miR-135a |
Down |
Gastric cancer, non-small cell lung cancer |
Suppression |
Suppression |
FAK, IGF-1 |
95, 96 |
miR-218 |
Down |
Gastric cancer |
Suppression |
Suppression |
ROBO1 |
99, 100 |
miR-320 |
Down |
Oral squamous cell carcinoma, cholangiocarcinoma |
Suppression |
Suppression |
Neuropilin 1 |
104, 105 |
miR-409-3p |
Down |
Fibrosarcoma |
Suppression |
Suppression |
Angiogenin |
108 |
miR-590-5p |
Down |
Colorectal cancer |
Suppression |
Suppression |
NF90 |
112 |
miR-1301 |
Down |
Hepatocellular carcinoma |
Suppression |
Suppression |
BCL9 |
114 |
miR-93 |
Up |
Breast cancer |
Promotion |
Promotion |
Integrin-beta8, LATS2 |
120, 121 |
miR-378 |
Up |
Non-small cell lung cancer |
Promotion |
Promotion |
Sufu, Fus-1, HMOX1 |
125, 126 |
miR-155 |
Up |
Breast cancer |
Promotion |
Promotion |
VHL, C/EBPbeta |
129, 131 |
miR-494 |
Up |
Lung cancer |
Promotion |
Promotion |
NOTCH1, PTEN |
135, 136 |
miR-296 |
Up |
Prostate cancer |
Promotion |
Promotion |
HGS, ICAM1 |
139, 142 |
miR-1246 |
Up |
Colorectal cancer |
Promotion |
Promotion |
PML, CCNG2 |
145, 146 |
miR-181a |
Up |
Chondrosarcoma |
Promotion |
Promotion |
RGS16 |
152 |
miR-221/222 |
Up |
Thyroid carcinoma, glioma |
Promotion |
Promotion |
ADIPOR1, TIMP2 |
153, 156 |